Market Overview

USPTO Affirms Gevo's Request for Reexamination of Butamax Patent


Gevo, Inc. (NASDAQ: GEVO) announced today that the U.S. Patent Office and Trademark (USPTO) has denied a petition by ButamaxTM Advanced Biofuels, LLC (Butamax) which would have vacated the order granting Gevo's reexamination request of Butamax's U.S. Patent No. 7,851,188.

In so doing, the USPTO simultaneously affirmed its original decision that all claims challenged by Gevo in the '188 patent remain rejected as unpatentable.

Posted-In: News FDA


Related Articles (GEVO)

View Comments and Join the Discussion!

Get Benzinga's Newsletters